OKC VeloCity | Blog
Economy / March 24, 2025

Wheeler Bio secures $35 million in oversubscribed Series A-1 round to accelerate growth, expand drug development and boost biomanufacturing capabilities

Wheeler Bio announced its successful completion of an oversubscribed Series A-1 financing round, meaning the Oklahoma City-based company attracted more investor interest and funding offers than initially sought, a strong indicator of confidence in the company’s growth and potential. The $35 million round was led by Alloy Therapeutics and Echo Investment Capital (Echo), with additional participation from Mitsubishi Corp. (Americas), Germin8 Ventures and Russell Westbrook Enterprises.

By Lauren King
Inside OKC / November 14, 2024

Q&A with Michelle Gregory: Director of Life Science Oklahoma

Life Science Oklahoma, the state’s life science association, recently appointed Michelle Gregory as its new director. Gregory has a history of leadership in nonprofit organizations in the healthcare sector. Gregory sat down with the VeloCity team to discuss her role as director of Life Science Oklahoma.

By Chamber Staff
Inside OKC / September 30, 2024

OMRF receives $3.7 million for Alzheimer’s research

The National Institute on Aging, part of the National Institutes of Health (NIH), has awarded the Oklahoma Medical Research Foundation (OMRF) a $3.7 million, five-year grant to study immune reactions in the brain, which could lead to conditions like Alzheimer’s disease.

By Chamber Staff
VeloCity Q&A / March 16, 2022
Dr. Andew Weyrich
President,
Oklahoma Medical Research Foundation
We were attracted to OMRF and Oklahoma City because of the people in Oklahoma and the opportunities here.
READ MORE